Lapatinib Ditosylate Monohydrate CAS 388082-78-8 Kemurnian >99,0% (HPLC)
Jeneng Kimia | Lapatinib Ditosylate Monohydrate |
sinonim | N-[3-chloro-4-[(3-fluorophenyl)methoxy]fenil]-6-[5-[(2-methylsulfonylethylamino)metil]furan-2-yl]quinazolin-4-amine |
Nomer CAS | 388082-78-8 |
Status Simpenan | Ing Simpenan |
Formula Molekul | C29H26ClFN4O4S·2(C7H8O3S)·H2O |
Bobot Molekul | 943.48 |
COA & MSDS | kasedhiya |
asale | Shanghai, China |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Kuning pucat nganti bubuk kristal kuning |
Kemurnian / Metode Analisis | ≥99,0% (HPLC) |
Titik Lebur | 240.0~242.0 ℃ |
Kelembapan (KF) | 1,9~2,4% |
Impurity Tunggal | ≤0,50% |
Total Impurities | ≤1,00% |
Logam Berat (Pb) | ≤20ppm |
Test Standar | Standar Perusahaan |
Panggunaan | API;Kanggo perawatan pasien kanker payudara |
Paket: Botol, tas Aluminium foil, 25kg / Karton Drum, utawa miturut kabutuhan pelanggan
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan
Lapatinib Ditosylate Monohydrate (CAS: 388082-78-8) yaiku uyah ditosylate sakaCAS 231277-92-2, quinazoline sintetik, aktif kanthi lisan kanthi aktivitas antineoplastik potensial.Iki mbalikke mblokir fosforilasi saka reseptor faktor pertumbuhan epidermis (EGFR), ErbB2, lan kinase Erk-1 lan-2 lan AKT;uga nyegah tingkat protein cyclin D ing garis sel tumor manungsa lan xenografts.EGFR lan ErbB2 wis kena pengaruh ing tuwuhing macem-macem jinis tumor.Iki diluncurake kanggo perawatan kanker payudara positif HER2 (ErbB2) lanjut utawa metastatik ing wanita sing wis nampa terapi sadurunge.Obat kasebut ditemokake lan dikembangake dening GlaxoSmithKline.